Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 195 entries
View as:

Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01165385 Org: User:
Start: 06/30/10 End: 10/31/14 Due: 10/31/15

Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema Occurrence

Phase: N/A Priority: Normal
NCT ID: NCT03127995 Org: User:
Start: 09/30/16 End: 09/30/30 Due: 09/30/31

Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00541112 Org: User:
Start: 10/29/07 End: 01/29/10 Due: 01/29/11

Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03838263 Org: User:
Start: 07/25/19 End: 11/20/24 Due: 11/20/25

Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations

Phase: N/A Priority: Normal
NCT ID: NCT04357873 Org: User:
Start: 10/28/20 End: 11/26/24 Due: 11/26/25

Sequences Of REGorafenib And Trifluridine/Tipiracil in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04450836 Org: User:
Start: 11/23/20 End: 12/31/24 Due: 12/31/25

Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour

Phase: N/A Priority: Normal
NCT ID: NCT06524583 Org: User:
Start: 01/27/25 End: 12/31/30 Due: 12/31/31

Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005944 Org: User:
Start: 07/01/99 End: 10/01/03 Due: 10/01/04

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT01994239 Org: User:
Start: 12/31/12 End: 03/31/25 Due: 03/31/26

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT03518606 Org: User:
Start: 06/20/18 End: 12/19/24 Due: 12/19/25

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003607 Org: User:
Start: 12/31/97 End: 01/31/15 Due: 01/31/16

High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted Agents

Phase: N/A Priority: Normal
NCT ID: NCT01414933 Org: User:
Start: 05/31/11 End: 05/31/13 Due: 05/31/14

Study Comparing Fibula Free-flap MR With or Without PVP in Patients With OOPC

Phase: N/A Priority: Normal
NCT ID: NCT04725396 Org: User:
Start: 04/20/21 End: 09/01/25 Due: 09/01/26

TARGETed Therapy Drug MONITOring in DIGestive Oncology

Phase: N/A Priority: Normal
NCT ID: NCT05443087 Org: User:
Start: 08/29/22 End: 06/30/27 Due: 06/30/28

Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk

Phase: N/A Priority: Normal
NCT ID: NCT05297617 Org: User:
Start: 10/12/22 End: 11/30/35 Due: 11/30/36

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01957436 Org: User:
Start: 11/13/13 End: 12/31/32 Due: 12/31/33

Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01780220 Org: User:
Start: 12/31/12 End: 01/07/22 Due: 01/07/23

Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00104689 Org: User:
Start: 06/30/03 End: 01/31/08 Due: 01/31/09

Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1

Phase: N/A Priority: Normal
NCT ID: NCT02034981 Org: User:
Start: 08/31/13 End: 12/06/23 Due: 12/06/24

Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00423696 Org: User:
Start: 03/23/06 End: 08/01/11 Due: 08/01/12

QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise Program

Phase: N/A Priority: Normal
NCT ID: NCT03169075 Org: User:
Start: 07/11/17 End: 07/11/28 Due: 07/11/29

Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer

Phase: N/A Priority: Normal
NCT ID: NCT03777813 Org: User:
Start: 12/05/18 End: 09/01/25 Due: 09/01/26

Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients

Phase: N/A Priority: Normal
NCT ID: NCT01415674 Org: User:
Start: 01/31/12 End: 12/31/21 Due: 12/31/22

IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting

Phase: N/A Priority: Normal
NCT ID: NCT02967289 Org: User:
Start: 03/27/17 End: 06/30/27 Due: 06/30/28

Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03809455 Org: User:
Start: 02/01/20 End: 02/01/23 Due: 02/01/24